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Abstract
Background: The aim of this study was to investigate whether body composition, dietary pattern and habitual
physical activity are associated with BMD according to time since menopause in women from Southern Brazil with
no clinical evidence of disease.
Methods: 99 participants were enrolled and anthropometry, body composition and BMD by dual energy x-ray
absorptiometry, rest metabolic rate by indirect calorimetry, dietary pattern by semi quantitative food frequency
questionnaire and habitual physical activity by pedometer were performed.
Results: Mean age was 55.2 ± 4.9 years and mean time since menopause was 6.8 ± 1.0 years. Weight, BMI, lean and
fat mass and RMR were higher in women with less than 5 years since menopause with normal versus low bone
mass. No differences were found in the studied variables between participants with normal or low bone mass and
more than 5 years of menopause. Women with > 5 years since menopause had higher prevalence of osteoporosis,
as well as lower BMD in all sites when compared to those with less time since menopause. Calories, carbohydrate,
protein, fat and micronutrients intake were similar between groups. When the sample was adjusted for time since
menopause, the odds ratio (OR) for low bone mass was 5.21 (95 % CI 1.57–17.25, P = 0.004) for BMI <25 kg/m2,
for lean mass <37.5 Kg an OR of 4.4 (95 % CI 1.64–11.80, P = 0.004, for fat mass <26.0 Kg an OR of 3.39 (95 % CI
1.29–8.85, P = 0.010) and for the intake of vitamin A < 700 mcg/day an OR of 3.00 (95 % CI 1.13–7.94, P = 0.012).
Low meat and eggs intake or low protein intake did not influence the odds ratio for low bone mass.
Conclusion: In this cross-sectional study with postmenopausal women with no clinical evidence of disease, time
since menopause, low lean and fat mass were associated with low bone mass. Calories and macronutrients intake
as well as habitual physical activity did not interfere with BMD, but participants were mostly sedentary. Further
studies are needed in order to determine whether the adequate intake of specific food groups and the type of
physical activity could attenuate the time since menopause impact on BMD.
Keywords: Menopause, Diet, Bone mass density, Lean mass, Osteoporosis, Lifestyle
* Correspondence: spritzer@ufrgs.br
1Gynecological Endocrinology Unit, Division of Endocrinology, Hospital de
Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, 90035-003 Porto
Alegre, RS, Brazil
2Laboratory of Molecular Endocrinology, Department of Physiology,
Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos,
2350, 90035-003 Porto Alegre, RS, Brazil
© 2015 Silva et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Silva et al. BMC Endocrine Disorders  (2015) 15:71 
DOI 10.1186/s12902-015-0072-8
Background
Bone mineral density (BMD) declines with increasing age,
and the rate of decline is more pronounced after meno-
pause [1]. Falling levels of 17-β-estradiol are thought to
accelerate the decline in BMD, which remains the single
best predictor of primary osteoporotic fracture [2]. This
decline can also be attributed to a number of factors: age,
genetics, nutrition, lifestyle factors, or the prolonged use
of certain medication [3].
Body mass index (BMI) is known to be positively corre-
lated with BMD, and low BMI (<19 kg/m2) significantly
increases the risk of osteoporosis in postmenopausal
women as compared to normal range BMI [4]. However,
the contributions of lean and fat body mass to BMD, re-
lated to BMI stratus, are still not completely understood
in different populations [5].
Lifestyle factors, such as physical activity (PA) and diet
may exert influence on BMD in both pre- and postmen-
opausal women. PA plays a major role in minimizing
bone loss as we age [6]. In addition, adequate dietary be-
havior seems to also influence on bone loss in postmen-
opausal women. In this sense, several studies had
previously underline the importance of adequate calcium
and Vitamin D levels in the prevention of osteoporosis
and fractures in the peri- and post-menopause [7–10].
Besides that, studies have shown that diets with high
content in vegetables, fruit, and whole grains may be as-
sociated with lower premenopausal bone loss in meno-
pausal transition and lower risk of low-trauma fracture,
particularly in older women [11, 12].
Therefore, the aim of this study was to investigate
whether body composition, dietary pattern and habitual
physical activity are associated with BMD according to
time since menopause in women from Southern Brazil
with no clinical evidence of disease.
Methods
Subjects
This cross-sectional study was carried out at the
Gynecological Endocrinology Unit at Hospital de Clínicas
de Porto Alegre, Brazil, from October 2010 to February
2012. Participants were recruited by advertisement in a
local newspaper and radio station. Inclusion criteria were
as follows: 1) menopause, defined as last menstrual period
at least 1 year before the beginning of the study plus fol-
licle stimulating hormone (FSH) levels > 35 IU/L; 2) age
between 45 and 65 years; and 3) no use of hormone ther-
apy in the past 3 months. Diabetic patients, patients with
prior diagnosis of heart disease, and current smokers were
excluded. These criteria were chosen because of the inter-
est to study women with no clinically established systemic
diseases. One hundred and nineteen postmenopausal
women fulfilling all the inclusion criteria were consecu-
tively enrolled. They were stratified by time since
menopause (≤5 or > 5 years) and BMD (low or normal
bone mass). The study protocol was approved by the local
Research Ethics Committee from Hospital de Clinicas de
Porto Alegre, and written informed consent was obtained
from every participant.
Design
All participants completed a questionnaire about their
sociodemographic characteristics (e.g., age, education,
household income, and marital status) and medical history
(including current medications). The variable skin color
was defined by auto-reference: participants were asked
about their skin color and were stratified in white and no
white. Anthropometric measurements were performed in
duplicate and included body weight, height, and waist cir-
cumference [13]. BMI (kg/m2) was calculated. Resting
metabolic rate (RMR) was obtained by indirect calorim-
etry (Fitmate®, Cosmed, Rome, Italy). Blood pressure was
measured after resting for 10 min, in the sitting position.
Two measurements were performed at a 10-min interval,
using an automatic blood pressure monitor (Omron HEM
742, Rio de Janeiro, Brazil) with an appropriate cuff
for the arm diameter. FSH, estradiol, total testosterone,
sex-hormone binding globulin (SHBG), ultrasensitive C-
reactive protein (us-CRP), total and high-density lipopro-
tein (HDL) cholesterol, triglycerides, fasting glucose and
insulin were determined using the 12 h fasting blood sam-
ple. All samples were obtained between 8 AM and 10 AM,
and were run immediately after collection. The methods of
analysis did not change during the entire study.
Assays
Total cholesterol, HDL cholesterol and triglycerides
were determined by colorimetric-enzymatic methods
(Bayer 1800 Advia System), with intra and interassay co-
efficients of variation (CV) < 3 %. Glucose was deter-
mined by the hexokinase method (Advia 1800) with
intra-assay CV < 3.4 % and interassay CV < 2.1 %. FSH
was measured by chemiluminescence immunoassay
(CLIA) (Centaur XP), with sensitivity of 0.3 IU/L and
intra and interassay CV of 2.9 and 2.7 % respectively.
Total testosterone levels were also measured by CLIA
(Centaur XP) with sensitivity of 10 ng/mL and intra and
interassay CV of 3.3 and 7.5 % respectively. SHBG was
measured by CLIA (Immulite 2000), with sensitivity of
0.02 nmol/L and intra- and interassay CV of 5.3 and
6.6 % respectively. Serum insulin levels were measured
using CLIA (Centaur XP), with a sensitivity of 0.200
μIU/mL and intra- and interassay CV of 2.0 and 4.3 %
respectively. FAI was estimated by dividing TT (in nano-
moles per liter) by SHBG (in nanomoles per liter) × 100.
Low-density lipoprotein (LDL) cholesterol was deter-
mined indirectly using the Friedewald formula LDL =
total cholesterol – HDL – (triglycerides/5). Homeostasis
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model assessment (HOMA) was calculated by multiply-
ing insulin (μIU/ml) by glucose (mmol/l) and dividing
this product by 22.5.
Bone mass and body composition assessments
BMD was assessed in lumbar spine (L1-L4), femoral
neck and proximal total femur by dual-energy X-ray ab-
sorptiometry (DXA) (GE Lunar Prodigy, Radiation
Corporation, Madison, WI, USA). BMD was expressed
by g/cm2 and T-scores. Normal bone mass was defined
as a T score above −1 standard deviations (SD) and low
bone mass was defined as the presence of at least one
site of osteopenia or osteoporosis, according to the
World Health Organization (WHO) [14].
A whole body scan was also performed by DXA to as-
sess body composition. Lean mass and fat mass were de-
termined for the whole body, with a CV lower than 2 %.
Dietary assessment
Usual dietary intake was assessed with a validated food fre-
quency questionnaire consisting of 120 items [15]. Nutri-
tional composition was calculated using the Brazilian Table
of Food Composition [16] except for vitamin D, E, and A,
which were assessed using the United States Department
of Agriculture (USDA) National Standard Reference Data-
base. Reference values for daily dietary intake were based
on national [17] and international guidelines [18].
Physical activity assessment
Assessment of habitual PA was performed with a digital
pedometer (BP 148, Tech Line, São Paulo, Brazil). The de-
vice was configured individually according to weight (kg)
and individual step length. The equipment was used for six
consecutive days, providing a weekly average number of
steps. Participants were stratified in active >6000 steps per
day) or sedentary ≤ 6000 steps per day), according to previ-
ously reported [15, 19, 20]. Subjects were encouraged not
to change their physical activity habits during the study.
Sample size estimation and statistical analyses
Sample size was estimated based on a previous study
[21], considering a power of 80 % and alpha of 5 %. One
hundred women were required to detect a difference of 4.3
in BMI between women with normal and low bone mass.
Results are presented as mean ± standard deviation
(SD), or median and inter-quartile range, depending on
the Gaussian or non-Gaussian distribution of variables.
Two-way ANOVA was used to assess the simultaneous
effects of time since menopause and BMD. χ2 was calcu-
lated for comparisons of dichotomous variables. A logis-
tic regression model was used to estimate the odds ratio
of different variables forlow bone mass, which was con-
sidered as the dependent variable. All analyses were
performed using the Statistical Package for the Social
Sciences 19.0 (SPSS, Chicago, IL, USA). Data were con-
sidered to be significant at p < 0.05.
Results
Of 119 volunteers, 13 were excluded (five with dia-
betes, one with hyperthyroidism, two with untreated
hypothyroidism, two with breast cancer, one who was
premenopausal and two with spinal disc prosthesis).
An additional seven participants dropped out because
they were unable to commit to the study (no time for
blood collection, DXA and indirect calorimetry). Thus, 99
women were enrolled. Mean age was 55.2 ± 4.9 years and
mean time since menopause was 6.8 ± 1.0 years. Partici-
pants had attended school for a mean of 8.5 ± 4.2 years,
and 87 % were white. Forty participants were on antihy-
pertensive drugs, two women were on statins, and one
was taking aspirin.
Table 1 presents the demographic, hormonal and body
composition characteristics of participants according to
time since menopause (≤5 or > 5 years) and BMD (low
or normal). The groups were similar regarding years at
school, skin color, estradiol and free estradiol index.
Number of steps per day, as an index of habitual physical
activity was low and similar between groups and the
prevalence of sedentary was around 50 and 70 % among
groups. In turn, participants with ≤ 5 years since meno-
pause presented higher weight, BMI, body fat %, lean
mass, fat mass and RMR in the normal bone mass sub-
group as compared to the group with low bone mass.
Lumbar spine, femoral neck, and total femoral BMD were
lower in both subgroups of low bone mass. Women with >
5 years since menopause and with low bone mass pre-
sented the lowest BMD in all sites in comparison with
women with low bone mass and with ≤ 5 years. In
addition, as shown in Fig. 1, women with > 5 years since
menopause had also higher prevalence of osteoporosis.
Calories, carbohydrate, protein, fat and micronutrients
intake were similar between groups (data not presented).
Vitamin A intake was greater in the groups with normal
bone mass compared to groups with low bone mass,
with a borderline significance (1239.7 ± 778.6 vs 926.8 ±
819.0 for groups with ≤ 5 years since menopause and
1363.4 ± 1199.4 vs 895.1 ± 871.0 for those with >5 years
of menopause; P = 0.051).
Table 2 shows lumbar spine, femoral neck and total
femoral BMD in postmenopausal women according to
different factors, stratified by tertiles. Age, time since
menopause, fat mass, and RMR were associated with
BMD in all sites. BMI was associated with BMD on fem-
oral neck and total femoral but not in the lumbar spine.
None dietary or hormonal variables were associated with
BMD (data not presented).
Compared with women who underwent menopause
≤5 years, those who underwent menopause >5 years ago
Silva et al. BMC Endocrine Disorders  (2015) 15:71 Page 3 of 8
had a 3-fold increase in odds ratio for low bone mass
(95 % CI 1.27–7.34, P = 0.016). However, being older
than 55 years (mean age of participants in this sample)
did not increase the odds ratio for low bone mass.
Therefore, when adjusted for time since menopause and
previous hormone therapy the odds ratio (OR) for low
bone mass was 5.21 (95 % CI 1.57–17.25, P = 0.004), for
BMI <25 kg/m2, for lean mass <37.5 Kg an OR of 4.4
(95 % CI 1.64–11.80, P = 0.004, for fat mass <26.0 Kg an
OR of 3.39 (95 % CI 1.29–8.85, P = 0.010) and for the in-
take of vitamin A < 700 mcg/day an OR of 3.00 (95 % CI
1.13–7.94, P = 0.012). Low meat and eggs intake or low
protein intake (defined as the median consumption of
participants in this sample) did not influence the odds
ratio for low bone mass (Table 3).
Discussion
In the present study, weight, BMI, lean and fat mass and
RMR were higher in postmenopausal women with less
than 5 years since menopause with normal versus low
bone mass. Interestingly, these variables did not differ
significantly between women with normal and low bone
mass and more than 5 years since menopause. This ob-
servation seems to support previous evidence showing
Table 1 Characteristics of postmenopausal women according to time since menopause and bone mass status
≤5 years since menopause >5 years since menopause
Normal bone mass Low bone mass Normal bone mass Low bone mass P value
(n = 21) (n = 28) (n = 10) (n = 40) Time since menopause BMD T x B1
Age (years) 52.2 ± 4.2a 52.1 ± 3.3a 55.9 ± 4.4b 58.9 ± 3.8c <0.001 0.096 0.076
Years at school (years) 9.5 ± 3.4 8.3 ± 4.5 6.2 ± 3.3 8.5 ± 4.7 0.120 0.535 0.079
White, n (%)d 19 (90) 24 (86) 8 (80) 35 (87) 0.688
Weight (kg) 77.9 ± 15.2b 62.7 ± 8.6a 69.5 ± 9.4b 65.5 ± 11.0ba 0.282 <0.001 0.033
BMI (kg/m2) 30.6 ± 5.8b 25.6 ± 2.9a 27.4 ± 3.5b 26.3 ± 4.3ba 0.189 0.002 0.050
Waist circumference (cm) 95.4 ± 14.8b 82.5 ± 7.9a 87.6 ± 8.9b 84.4 ± 10.7ba 0.239 0.002 0.054
Body fat % 44.2 ± 5.6b 39.5 ± 6.2a 41.3 ± 4.8b 38.9 ± 6.2ba 0.262 0.025 0.453
Lean mass (kg) 41.3 ± 5.9b 35.6 ± 4.2a 38.7 ± 5.3b 37.7 ± 3.8ba 0.797 0.002 0.027
Fat mass (kg) 33.7 ± 10.3b 25.2 ± 9.6a 27.5 ± 6.2b 25.0 ± 8.7ba 0.131 0.010 0.159
RMR (Kcal/day) 1358.4 ± 285.8b 1191.8 ± 134.8a 1302.0 ± 189.8b 1242.5 ± 165.3ba 0.949 0.012 0.227
Mean steps/day 3681.6 ± 208.8 3718.9 ± 262.3 3659.1 ± 225.7 3731.0 ± 243.8 0.925 0.323 0.754
Sedentary, n (%)d 14 (67) 16 (57) 7 (70) 21 (52) 0.564
Lumbar spine BMD (g/cm2) 1.20 ± 0.08c 1.00 ± 0.08b 1.19 ± 0.09c 0.94 ± 0.13a 0.139 <0.001 0.352
Femoral neck BMD (g/cm2) 1.01 ± 0.08c 0.88 ± 0.08b 0.98 ± 0.07c 0.80 ± 0.09a 0.027 <0.001 0.344
Total femoral BMD (g/cm2) 1.07 ± 0.09c 0.92 ± 0.09b 1.02 ± 0.08c 0.86 ± 0.10a 0.015 <0.001 0.744
Estradiol (pg/mL) 27.6 ± 15.7 22.2 ± 12.6 20.9 ± 10.4 20.1 ± 11.9 0.178 0.191 0.583
Free estradiol index (pg/mL) 0.4 ± 0.2 0.3 ± 0.2 0.3 ± 0.1 0.3 ± 0.2 0.178 0.191 0.583
Values are expressed as mean ± SD, median and 25–75 inter-quartile range or absolute and percentage number
BMI body mass index, RMR resting metabolic rate, BMD bone mineral density. 1T × B = Time since menopause × Bone Mineral Density interaction effect. a-cMeans in
a row without a common superscript letter differ (P < 0.05), as analyzed by two-way ANOVA and Bonferroni test. dQui-square Test. p values in boldface reflect
statistical significance
Fig. 1 Prevalence of osteoporosis, osteopenia, and normal bone mass in women grouped according to time since menopause (≤5 and > 5 years)
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that BMD is better correlated with percentage of body fat
in pre- and perimenopausal than in postmenopausal
women [22]. In addition, while it is known that total BMD
is associated with higher BMI and fat mass, the profile of
trabecular and cortical volumetric BMD (vBMD) varies ac-
cording to BMI. Indeed, obese adults present higher tra-
becular vBMD but lower cortical vBMD [23]. Therefore,
we hypothesize that the association of adiposity and BMD
was more evident in recent postmenopausal women be-
cause they had more trabecular bone than those in later
postmenopausal life (in whom trabecular bone is lost due
to the high bone turnover occurring throughout the post-
menopausal years). Further studies assessing volumetric
bone density and microarchitecture by high-resolution per-
ipheral quantitative computed tomography in postmeno-
pausal populations are needed to confirm this hypothesis.
When the entire sample was analyzed, age, time since
menopause, fat mass and RMR were associated with
BMD in all three sites.
In fact, menopause is associated with a few years of
rapid bone loss attributed to lower circulating levels of
17β-estradiol, related primarily to the decline in
estrogen-mediated inhibition of bone resorption without
a fully compensatory increase in bone formation [2]. For
an interval of few years around the menopause, women
lose 2 % of bone annually. Afterward, bone loss slows to
about 1 to 1.5 % per year [24, 25]. Recker et al., [25]
found that menopausal bone loss is a composite of loss
Table 2 Lumbar spine, femoral neck and total femoral bone mineral density in postmenopausal women according to factors







Age (years) ≤53 37 1.11 ± 0.13a 0.002 0.94 ± 0.11a <0.001 1.00 ± 0.11a <0.001
53–58 31 1.00 ± 0.15b 0.88 ± 0.11a 0.93 ± 0.11b
≥58 31 0.98 ± 0.14b 0.81 ± 0.09b 0.88 ± 0.11b
Time since menopause (years) ≤3 34 1.08 ± 0.13a 0.002 0.91 ± 0.11a 0.008 0.98 ± 0.12a 0.002
3–8 32 1.07 ± 0.15a 0.90 ± 0.11a 0.96 ± 0.11a
≥8 33 0.96 ± 0.15b 0.83 ± 0.11b 0.88 ± 0.12b
BMI (kg/m2) ≤25 33 1.00 ± 0.13 0.086 0.82 ± 0.10a 0.001 0.87 ± 0.10a
25–28.2 34 1.04 ± 0.14 0.91 ± 0.10b 0.97 ± 0.10b <0.001
≥28.2 32 1.08 ± 0.17 0.91 ± 0.12b 0.98 ± 0.13b
Fat Mass (kg) ≤23.4 33 1.01 ± 0.13a 0.005 0.84 ± 0.12a 0.016 0.89 ± 0.1 a 0.003
23.4–29.8 34 1.01 ± 0.17a 0.89 ± 0.12ab 0.94 ± 0.13ab
≥29.8 32 1.11 ± 0.13b 0.92 ± 0.10b 0.99 ± 0.110b
Lean Mass (kg) ≤36.0 34 1.02 ± 0.15 0.108 0.86 ± 0.10 0.92 ± 0.10
36.0–39.2 33 1.02 ± 0.14 0.87 ± 0.12 0.086 0.93 ± 0.13 0.130
≥39.2 32 1.08 ± 0.15 0.92 ± 0.12 0.98 ± 0.12
Estradiol (pg/mL) ≤15 34 1.00 ± 0.14 0.252 0.85 ± 0.12 0.91 ± 0.13 0.102
15–26 33 1.04 ± 0.16 0.88 ± 0.12 0.069 0.94 ± 0.13
≥26 32 1.07 ± 0.15 0.91 ± 0.10 0.97 ± 0.10
Free estradiol (pg/mL) ≤0.20 33 0.99 ± 0.14 0.207 0.84 ± 0.12a 0.053 0.91 ± 0.13 0.093
0.2–0.35 32 1.04 ± 0.15 0.89 ± 0.12ab 0.94 ± 0.13
≥0.35 34 1.07 ± 0.15 0.91 ± 0.10b 0.97 ± 0.10
RMR (Kcal) ≤1175 33 1.01 ± 0.15a 0.005 0.85 ± 0.11a 0.046 0.90 ± 0.10 0.028
1175–1324 35 1.00 ± 0.14a 0.89 ± 0.11ab 0.95 ± 0.13
≥1325 31 1.01 ± 0.13
a-bMeans in a column without a common superscript letter differ (P < 0.05), as analyzed by one-way ANOVA and the Bonferroni test. p values in boldface reflect
statistical significance
Table 3 Odds ratio for low bone mass
Variables OR 95 % CI P*
BMI (<25 kg/m2)a 5.21 1.57 – 17.25 0.004
Lean Mass (<37.5 kg)b 4.40 1.64 – 11.80 0.004
Fat Mass (<26.0 kg)b 3.39 1.29 – 8.85 0.010
Vitamin A (<700 mcg/day)c 3.00 1.13 – 7.94 0.012
Meat and eggs (<96 g/day)b 2.30 0.90 – 5.86 0.081
BMI body mass index. *Logistic regression adjusted for time since menopause
and previous hormonal therapy. aDefined as the first tertile of the studied
sample; bdefined as the median of participants in this sample; cDietary
Reference Intake (2002) values in boldface reflect statistical significance
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caused by estrogen deprivation and age per se for the
hip and total body, but is caused by estrogen deprivation
alone for the spine. In the Study of Women’s Health
Across the Nation (SWAN), women who transitioned
through menopause experienced a significantly higher
rate of bone loss than women who remained premeno-
pausal, independent of age [26]. In turn, a recent study
suggests that time since menopause may have a stronger
predictive value for low BMD in the lumbar and hip
areas than did serum FSH or estradiol levels [27]. Data
from the present study reinforces that idea, showing that
women with more than 5 years since menopause had
higher prevalence of osteoporosis, as well as lower BMD
in all sites when compared to those with less time since
menopause. In addition, women who underwent meno-
pause more than 5 years ago had a 3-fold increased odds
ratio for low bone mass.
Regarding the association between BMD and BMI we
found in our study, the odds ratio for low bone mass
was five times for a BMI lower than 25 kg/m2, being this
cut-off the lowest tertile of our sample. In this sense,
low weight or low BMI is a well-documented risk factor
for future fracture [1]. Zhu and coworkers have recently
reported in a Western Australian population that the as-
sociations of BMI with BMD measures were attenuated
in those with high BMI [5], suggesting that low body
weight should be considered as a risk factor for osteo-
porosis and related fracture, rather than obesity being a
protective factor.
In the present study fat mass was associated with BMD
in all sites and with reduced odds ratio for low bone mass.
However, the influence of fat mass on BMD is a debatable
issue and seems to be related to menopausal status [28].
In postmenopausal women, adipose tissue is the major
sources of estrogen from aromatization [29]. Therefore, it
has been suggested that subcutaneous adipose tissue have
higher aromatase activity in comparison to visceral adi-
pose tissue, and could exert a more beneficial effect than
visceral fat in bone health after menopause. In this sense,
body composition analysis by DXA does not allow to dis-
criminate subcutaneous and visceral fat, which is a limita-
tion of the present study. Further studies using other
methodologies are needed in order to clarify this issue.
While in our study BMD measures in all three sites
did not differ according to lean mass tertiles, lean mass
was lower in participants with low bone mass versus
normal bone mass and less than 5 years since meno-
pause. Lima and coworkers showed that in older women,
lean mass was significantly correlated with BMD inde-
pendently of height and fat mass [28]. Some other cross
sectional studies with postmenopausal women suggests
that lean mass is not an independent correlate of BMD
[30, 31]. In turn, in pre- and peri-menopausal women
lean mass has been reported to be a main predictor of
BMD [32, 33]. The stronger association between lean
mass and BMD may be attributed to differences in de-
terminants of lean mass, such as exercise, lifestyle fac-
tors, serum estrogen concentrations or a combination of
these factors [32].
Concerning RMR, studies in different populations have
also reported a strong relationship between BMD and
RMR [34, 35]. We found that participants with low bone
mass have lower RMR, in line with a previous research
that have also shown that a lower lean mass in postmen-
opausal women is associated with a lower RMR [36].
Taken together these data suggest that interventions
aiming to increase lean mass, which increases RMR,
could represent a simple and useful strategy to prevent
osteoporosis in women, especially in recent postmeno-
pausal women, such as physical activity (PA) practice. In
fact, intervention studies have reported positive effects or
associations between PA, BMD and markers of bone me-
tabolism in pre- and postmenopausal women [37, 38].
However, walking may not be enough as a stimulus to in-
crease lean mass in postmenopausal women [39], and
these women should be encouraged to participate in regu-
lar programs of moderate physical activity [40]. Indeed, in
the present study, participants were mostly sedentary, as
objectively estimated by a pedometer, and this could have
influenced on the association between lean mass and
BMD that was independent of habitual PA.
In the specific context of osteoporosis prevention and
management, a discussion of nutrition appropriately fo-
cuses on vitamin D, and protein in addition to calcium.
According to our data the mean calcium intake was
799 mg/day meaning 69 % of dietary reference intakes
for American women (1200 mg/day). However, in a lon-
gitudinal and prospective cohort study, based on the
Swedish MammographyCohort [39] only calcium intake
lower than 700 mg/day increased risk of fractures and of
osteoporosis, high levels of intake did not further de-
crease the rate of fracture [41]. In the same cohort al-
though not reflected in the fracture rate, women with
high vitamin D intake (>5.4 μg/day) tended to have a
slightly higher BMD, but in the present study vitamin D
(mean of intake 4 μg/day) did not influence the BMD. In
a recently published reanalysis of randomized vitamin D
supplementation trials, it was concluded that an intake
of 20 μg/day is needed to prevent nonvertebral fractures
in women and men aged 65 years or older [6]. Regarding
calories intake, a previous study showed higher cortical
BMD in elderly women (mean age of 75 years) eating a
diet exceeding the RDA for macronutrients (44 kcal/kg
of ideal body weight) [42]. Interestingly, we did not find
any association between calories intake and BMD, probably
because our participants were in early postmenopausal.
Dietary protein is positively linked to the maintenance of
bone and muscle health and some experts suggest that the
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current recommended protein intake (≈70 g/day) may be
inadequate for optimum skeletal and muscle health [43].
Our postmenopausal women had an average protein intake
of 77 g/day, which may not be sufficient for interfering
with the risk for low bone mass, as shown by the neutral
OR related to meat and eggs food intake.
In turn, when micronutrients intake was analyzed, only
vitamin A appears to be less consumed among women
with lower bone mass. Considering all sample, vitamin A
intake lower than 700mcg a day, that is the recommended
amount for dietary reference intakes [18], was related to a
higher OR for low bone mass. Indeed, vitamin A, retinol,
beta‐carotene, and its metabolites are involved in bone
metabolism and Wattanapenpaiboon et al. have shown a
positive correlation of lumbar BMD with β -carotene
levels in postmenopausal women [44]. A recent meta-
analysis, also reported an U‐shaped relationship between
serum retinol levels and hip fracture risk [45].
One limitation of the present study is the cross-
sectional design that does not allow conclusions regard-
ing the direction of cause and effect. Other limitation is
the relatively small sample size of 99 participants and a
moderate enrollment rate (16 % excluded participants),
which could affect the external validity. However, the re-
sults observed in our sample of Southern Brazilian post-
menopausal women are consistent and in line to those
reported in other populations. Another limitation is that
although pedometers are increasingly used to estimate
habitual physical activity, they are not sensitive to the in-
tensity or the type of the activity performed, and there-
fore may not accurately depict the loading forces of the
activities performed, which are important for bone
maintenance and/or development [38].
Conclusions
In postmenopausal women from Southern Brazil, with no
clinical evidence of disease, time since menopause, low
lean and fat mass were associated with low bone mass. Cal-
ories and macronutrients intake as well as habitual physical
activity did not interfere with BMD, but participants were
mostly sedentary. Further studies are needed in order to
determine whether the adequate intake of specific food
groups and the type of physical activity could attenuate the
aging and time since menopause impact on BMD.
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